Physician profile
Raymond Turner
NPI 1992980973
$1,322,476.40
in general payments reported to CMS, 2019-2025
25 companies · $21K in 2025
The $21K reported for 2025 was more than what 90% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $769K · 2020: $147K · 2021: $122K · 2022: $97K · 2023: $114K · 2024: $52K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $153K · Consulting Fee: $30K · Food and Beverage: $2,986 · Travel and Lodging: $1,169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $153,225.50 |
| Consulting Fee | $29,883.79 |
| Food and Beverage | $2,986.32 |
| Travel and Lodging | $1,168.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corindus INC. | $530,000.79 | 2019 | |
| Siemens Medical Solutions USA, INC. | $287,485.31 | 2019-2024 | Corpath Imaging System, Artis Icono Biplane |
| Medtronic, INC. | $214,732.49 | 2021-2025 | Pipeline, Intellis Adaptivestim, Onyx Frontier |
| Biosense Webster, INC. | $166,089.14 | 2019-2021 | |
| Medical Device Business Services, INC. | $60,296.55 | 2019-2020 | |
| Qapel Medical INC | $37,188.63 | 2021-2025 | |
| Rapid Medical Ltd | $10,536.00 | 2025 | Comaneci 17, Tigertriever 17 Revascularization Device |
| Medtronic USA, INC. | $8,360.60 | 2019-2020 | |
| Integra Lifesciences Corporation | $3,423.66 | 2019-2023 | Codman Certas, Cusa Clarity |
| Boston Scientific Corporation | $1,125.00 | 2025 | Enroute Transcarotid Neuroprotection System |
| Silk Road Medical, INC. | $937.50 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Depuy Synthes Sales INC. | $598.19 | 2019-2022 | |
| Stryker Corporation | $496.17 | 2019-2024 | Surpass Evolve |
| Microvention, INC. | $384.88 | 2019-2023 | Eric Retrieval Device |
| Vasorum USA INC. | $347.30 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Imperative Care, INC | $215.57 | 2019-2023 | Zoom Rdl Radial Access System, 103cm |
| Qfix | $66.02 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $50.82 | 2025 | Austedo Xr |
| Balt USA, LLC | $44.56 | 2020 | |
| Scientia Vascular | $37.66 | 2022 | |
| Depuy Synthes Products, INC. | $27.66 | 2019 | |
| Viz.Ai, INC. | $19.23 | 2022 | |
| Terumo Medical Corporation | $12.67 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$784,341.86 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.